Léri-Weill syndrome (LWS) or dyschondrosteosis represents a short stature syndrome characterised by the mesomelic shortening of the forearms and lower legs and by bilateral Madelung deformity of the wrists. Recently, mutations in the pseudoautosomal homeobox gene SHOX have been shown to be causative for this disorder. This gene has previously been described as the short stature gene implicated in Turner syndrome (TS). We studied 32 Léri-Weill patients from 18 different German and Dutch families and present clinical, radiological and molecular data. Phenotypic inter-and intrafamilial heterogeneity is a frequent finding in LWS, and phenotypic manifestations are generally more severe in females. In males, muscular hypertrophy is a frequent finding. To test for SHOX mutations we used FISH, Southern blot and SSCP analysis as well as long-range PCR and sequencing. We identified (sub)microscopic deletions encompassing the SHOX gene region in 10 out of 18 families investigated. Deletion sizes varied between 100 kb and 9 Mb and did not correlate with the severity of the phenotype. We did not detect SHOX mutations in almost half (41%) the LWS families studied, which suggests different genetic etiologies.
Introduction
Height and weight represent truly classic 'polygenic' characters. Although these traits are most likely determined by different environmental factors and small additive effects of many different genes, major genetic determinants for both height and weight have been characterised in recent years. One of them, SHOX, a homeobox-containing transcription factor, has been implicated in the final height of a person 1, 2 Haploinsufficiency of SHOX has been shown to be causative for the short stature phenotype associated with Turner syndrome and a certain proportion of 'idiopathic' shortstature patients (Rao et al 2 , and unpublished results, 1998).
Turner syndrome (TS) represents a frequent chromosomal disorder associated with partial or total loss of a sex chromosome. Significant clinical variability exists in the phenotype of females with TS, with gonadal dysgenesis and short stature as the key symptoms of this disorder. Despite the fact that short stature represents one of the leading symptoms, Turner females with normal stature (arbitrarily defined as being above the 3rd percentile of a given population) exist due, for example, to tall parents or other unknown factors. Different somatic features are found at different frequencies in Turner syndrome. 3 Among those, a skeletal deformity of the forearm, termed Madelung deformity, has been seen in up to 8% of females with TS.
This abnormality involving the shortening and bowing of the radius with a dorsal subluxation of the distal ulna has also been seen in one other syndrome, Léri-Weill syndrome (LWS). LWS or dyschondrosteosis, formerly thought to be inherited in an autosomal dominant manner, is characterised by mesomelic shortening of the forearms and lower legs and by a Madelung deformity of the wrists. 5 Despite the fact that females are more often and more severely affected than males, 6 two recent studies on 14 17 Hybridisation signals were detected via avidin-conjugated FITC. For SSCP analysis, oligonucleotide primer pairs specific for exons II, III, IV, V and VI were used as described. 2 For exon II, two additional primer pairs were used: primer pair for exon II, 5' splice site: SHOXIN1 FOR 5'-CCT CTC TCC AGC CGT GAA CTC CTT G-3' and SHOXEX2 REV 5'-CAG GTT ACC CGC GTT CTC TCC GTG-3' (T A 62°C; 98 bp product). Primer pair for exon II, 5' untranslated region: Pro FOR and Pro REV 5'-GTG CGC GCG GGT GGA TCA CCA GC-3' (T A 60°C; 140 bp product).
PCR amplification

Southern blot hybridisation
Southern blot hybridisations were carried out in Church buffer (0.5 M NaPi pH 7.2, 7% SDS, 1 mM EDTA) at 65°C in high stringency conditions and washed in 40 mM NaPi, 1% SDS, at 65°C.
SSCP analysis
SSCP analysis was performed on amplified genomic DNA from patients as described. 18 The PCR products (1-5 µl) were mixed with 5 µl of denaturation solution containing 95% formamide and 10 mM EDTA pH 8.0 and denatured at 95°C for 10 min. Samples were immediately chilled on ice and loaded on a 10% polyacrylamid gel (acrylamide: bisacrylamide = 37.5:1 and 29:1, multi-slot gel, TGGE base, Qiagen, Hilden, Germany) containing 2% glycerol and 1 ϫ TBE. Gels were run at 15°C, in 1 ϫ TBE, 500 V for 3 to 5 h and silverstained as described.
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Cloning and sequencing of PCR products PCR products were cloned into the pCR2.1-TOPO vector (Invitrogen, Groningen, Netherlands). Ten clones per exon were sequenced with Cy5-labelled vector primers M13, universal and reverse, by the cycle sequencing method described by the manufacturer (ThermoSequenase Kit, Amersham Pharmacia Biotech, Feiburg, Germany), and analysed on an ALFexpress automated sequencer (Pharmacia).
Results
Clinical findings and inheritance in patients with
Léri-Weill syndrome Bilateral Madelung deformity was present in all adult patients studied. All adults exhibited a clearly visible bayonet position of the hands ascertained by X-ray examination. Figure 1a and b show X-rays of the forearm of patients with and without SHOX mutation. First clinical signs of Madelung deformity such as triangulation of carpal bones and bowing of both forearm bones could be detected in children only by radiological examination. First radiological changes are already visible between 2 and 5 years of age. Height ranged from 135 to 164 cm (-6.4 to -0.6 SDS) in adult females and from 156 to 171 cm (-3.6 to -1.8 SDS) in adult males (Table 1) . Consequently short stature could not be diagnosed in two out of 18 adult females and in one out of five adult males. The SDS in five children (aged 6 to 15 years) ranged from -4.2 to -0.2 SDS (Table 1) . In 14 adult patients with SHOX mutation, the mean height SDS was -3.4, very similar to the -3.3 SDS in nine adult patients with no detectable SHOX mutation. Mesomelia was diagnosed in all 21 female patients (adults and children) and in five out of 11 males.
Athletic habitus was obvious in male patients, except for patient 7A, and in female patients 4A and 4B. This feature was overlooked in previous clinical evaluations, but seems to be frequent in LWS. Muscle MRI revealed this habitus to be due to true muscular hypertrophy (Figure 2 ). An underlying muscular disorder could be excluded by normal electromyography and normal levels of creatin kinase.
Seven out of 32 patients were sporadic cases (22%), all of them females. In the remaining 25 familial cases, maternal transmission could be observed in families 1, 4, 6, 8, 11 and 17, and paternal transmission in families 7, 10, 14, 16 and 18. In family 9, maternal transmission was apparent from grandmother to father, and paternal transmission from father to son ( Figure 6 ).
FISH analysis
To search for SHOX gene deletions, fluorescence in situ hybridisation (FISH) analysis was performed. SHOX containing cosmids LLN0YCO3'M'15D10 and LLN0YCO3'M'34F5, and a 12 kb BglII fragment from within cosmid 34F5 (containing SHOX exons II-VIa) were hybridised on metaphase chromosomes of all patients (except patient 7A, where no metaphases were available). A complete deletion of the cosmids could be detected in patients from families 1, 2, 4, 6, 11, 13, 14, 16, 17 and 18 ( Figure 3) .
A more detailed characterisation of the deletion breakpoints revealed six small interstitial PAR1 deletions on the X chromosome in patients 1A-D, 4A-B, 13, 14A, 16A and 18B, and on the Y chromosome in patients 14B, 16B and 18A. The deletion sizes in these families ranged from 150 kb to 450 kb ( Figure 4 ). In contrast, families 2, 6, 11 and 17 exhibited large deletions of approximately 6 Mb and 9 Mb in size. Families 2, 6 and 11 had terminal deletions (Figure 4 ).
Exclusion of microdeletions by long-range PCR and Southern blot analysis
Long-range PCR was carried out to exclude microdeletions of SHOX in patients without detectable SHOX deletions. For this purpose, genomic DNA from one member of each family was investigated by long-range PCR. The amplified PCR products covered most of the SHOX gene region (including exon II, IV, V, VIa and VIb) ( Figure 5 ). No specific long-range primer pairs Variation and heterogeneity in Léri-Weill syndrome S Schiller et al y for exon I and III could be established due to CG-rich repeats in these regions. In addition, Southern blot analysis was performed after digestion of genomic DNA with EcoRI of patients 3, 5, 9A, 12 and 15 using a SHOX cDNA probe covering exon II to VIa (exon I only includes noncoding 5' UTR). Neither intronic nor exonic microdeletions were detectable by long-range PCR and genomic Southern blot analysis (data not shown).
Mutation screening and sequencing in patients with no detectable SHOX deletion
One patient from each family without detectable SHOX deletion was analysed for point mutations or small rearrangements by single-strand conformation polymorphism (SSCP) analysis. Specific (intronic) primer pairs, originally designed for the SSCP analysis of patients with idiopathic short stature, 2 were used for this purpose. In addition to these primers, two new primer pairs of the 5' splice site and the 5' untranslated region of exon II were designed. Due to an unusually high frequency of CG-rich repeats, no specific primers could be created for exon I, which includes part of the 5' UTR. PCR products were analysed on SSCP gels using two different conditions. No band shifts were detected. To exclude the possibility of undetected point mutations or 
Discussion
We identified (sub)microscopic deletions encompassing the SHOX gene region in 10 out of 18 families investigated. Phenotypic manifestations of LWS (short stature, mesomelia and Madelung deformity) were independent of the presence or absence of SHOX mutations, yet generally more severe in females. Distinct clinical features can be found independently from each other, eg patients with mesomelia were not shorter than the other patients.
There were striking variations in final height between 135 and 164 cm (-6.4 to -0.6 SDS) in females and 156-171 cm (-3.6 to -1.8 SDS) in males with a deviation into the normal range. No differences between the mean height SDS of LWS patients with (-3.4 SDS) and those without SHOX mutation (-3.3 SDS) were evident. Striking inter-and intra-familial variations in height could be observed in the LWS patients. In family 1, for example, the SDS of height ranged from -1.5 to -4.7 in adult patients. Significant height variations have been previously described in patients with Turner syndrome 3 and hypochondroplasia. 20 In addition, the severity of mesomelia varied, but does not seem to be an essential clinical sign of LWS, since only some of the male patients investigated (remarkably all with SHOX deletions) exhibited this trait. Furthermore, a variability of the manifestation of Madelung deformity was observed even within the same family (eg families 1 and 16). Phenotypic heterogeneity and intrafamilial variability are frequently found in haploinsufficiency syndromes, 21 suggesting that multiple interactions of the participating determinants are particularly sensitive to disturbance, leading to imbalance. Phenotypic heterogeneity involving identical SHOX point mutations leading, for example, to proportionate short stature in otherwise normal individuals or to mesomelic short stature and Madelung deformity in Léri-Weill patients has been described previously. 2, 8 Modifier genes, intragenic sequence alterations, long-range effects, epistasis, epigenetic interactions and stochastic effects have been hypothesised to explain these still unusual phenomena (for a review see Wolf 22 ).
Inter-and intrafamilial variability may also be explained by the regulatory effects of sex steroids. Our clinical and molecular study has shown that muscular hypertrophy is associated with this syndrome and common in males. Recently, imprinted QTL with a major effect on muscle mass in pigs suggested the involvement of the IGF2 gene, expressed exclusively from the paternal allele. 23 In homozygous Splotch mutant mice (carrying mutations in the homeodomain of Pax-3) a specific disturbance of muscle development in the limbs is observed. 24 In fact, Pax-3 seems to be a key regulator of somitic myogenesis, mediating activation of MyoD, Myf-5 and myogenin in response to muscle-inducing signals. 25 The observed muscular hypertrophy in LWS males raises the possibility that SHOX (which shares 72% of the Pax-3 homeodomain) may in a direct or indirect way also be part of the hierarchical cascade of transcription factors regulating skeletal myogenesis. Since both alternatively spliced isoforms of SHOX, SHOXa and b, are expressed in skeletal muscle, 2 one may consider both gene products to be also involved in muscle development. Madelung deformity has been diagnosed in 8% of Turner patients, constituting one of the somatic Turner signs. 4 The basic question as to why only exceptional cases of patients with SHOX deletions (terminal Xp/Yp deletions), SHOX point mutations (idiopathic short patients) and a small percentage of Turner females present Madelung deformity remains unanswered. One may argue that LWS encompasses a subset of patients where SHOX gene mutations phenotypically lead to the Madelung deformity, the mesomelia and short stature, and thus overlaps with a subset of Turner features.
Figure 6
Pedigrees of the familial LWS cases presented in 26, 27 Secondly, clinical criteria for family selection may have slightly varied in the different groups. In our study, all patients showed the bilateral Madelung deformity. A clinical re-evaluation of our patients showed no significant differences in height between Léri-Weill patients with and those without SHOX mutations. Moreover, all studied females presented the mesomelia, and no differences in those with or without SHOX mutation were found. In contrast, all five males with a mesomelia presented SHOX mutations, whereas four males without mesomelia showed an absence of SHOX mutations. This suggests that LWS is a genetically heterogeneous disease involving mutations in different genes. More extensive genome-wide linkage studies on SHOX positive (non-deletion) families will be required to clarify this issue. The general association of SHOX mutations with LWS in most cases, however, confirms the importance of this gene in short stature phenotypes.
